Catalio Capital Management, LP
Catalio Genesis Fund III, LLC
Late investment period
Late investment period: first sale Oct 2021, per Form D (fund age approximates vintage)
- Vintage
- 2021
- Fund size
- $35M to $35.78M (Form D and SEC adviser filing)
- Stages
- Not stated
- Sectors
- Biotech, Medical devices, Healthtech, Digital health, Life sciences and research tools
- Regions
- Not stated
01 · Thesis
Catalio invests in innovative healthcare companies at all stages and sizes, across the capital structure. Its portfolio spans drugs, devices, diagnostics and AI-enabled companies, sourced partly through serial scientist-entrepreneur venture partners.Inferred from the firm's website
02 · Initial check
$350K to $596K (estimated from fund size)
Estimated from Form D and SEC adviser filing
03 · Who to approach
Named on this fund's Form D
- Georgios Petrocheilos, Manager and Member of Manager of the Issuer
- Rachel Vogelstein, Manager and Member of Manager of the Issuer
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideCatalio invests in innovative healthcare companies at all stages and sizes, across the capital structure.
At Catalio, we invest in innovative healthcare companies at all stages and sizes, and throughout the capital structure.
https://cataliocapital.com/
06 · Sources
Last verified: Oct 28, 2026